Evidence map›Paper›PMID 39864237›Full record

ArticleTuberculosis (Edinburgh, Scotland)2025

HIV co-infection is associated with increased HLA-DR expression by Mycobacterium tuberculosis-specific CD4 T cells in people with latent tuberculosis infection.

Jeremiah Khayumbi, Loren E Sasser, Taryn A McLaughlin, Joshua Ongalo, Joan Tonui, Samuel Gurrion Ouma, Angie Campbell, Felix Hayara Odhiambo, Neel R Gandhi, Chelimo Kiprotich and 1 more

Abstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jeremiah KhayumbiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya; Department of Biomedical Sciences, School of Public Health and Community Development, Maseno University, Kisumu, Kenya.
Loren E SasserEmory Vaccine Center, Emory University, Atlanta, GA, USA; Emory National Primate Research Center, Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Taryn A McLaughlinEmory Vaccine Center, Emory University, Atlanta, GA, USA; Emory National Primate Research Center, Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Joshua OngaloCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Joan TonuiCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Samuel Gurrion OumaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Angie CampbellDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Felix Hayara OdhiamboCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Neel R GandhiDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Chelimo KiprotichDepartment of Biomedical Sciences, School of Public Health and Community Development, Maseno University, Kisumu, Kenya.
Cheryl L DayEmory Vaccine Center, Emory University, Atlanta, GA, USA; Emory National Primate Research Center, Atlanta, GA, USA; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: cday@emory.edu.

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Role of antigen-specific T cell responses in the control of TBU19AI111211 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2020
$20.1M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI KLEIN, ROBERT STEPHEN · 2003 to 2013
$18.6M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
NK cell-mediated regulation of T cell immunity in TB/HIV co-infectionR01AI111948 · NIAID · EMORY UNIVERSITY · PI DAY, CHERYL LIANE · 2014 to 2018
$3.7M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
NIAID NIH HHS K24 AI114444NIAID NIH HHS P30 AI051519NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI111948NIAID NIH HHS U19 AI111211NIH HHS P51 OD011132
6 · The paper itself

Abstract

Infection with HIV is associated with dysregulated CD4 T cell responses to Mycobacterium tuberculosis (Mtb) and increased risk of developing tuberculosis. Mtb-specific CD4 T cells in people with HIV have diminished Th1 cytokine production capacity, thus we utilized a flow cytometry-based assay to measure CD40L expression by Mtb-specific CD4 T cells in a cytokine-independent manner. We evaluated the frequency and phenotype of Mtb-specific CD4 responses in Kenyan adults with latent Mtb infection and found that the majority of Mtb-specific CD4 T cells expressed CD40L in the absence of IFN-γ, regardless of HIV infection status. Expression of HLA-DR was increased on Mtb-specific CD4 T cells in people with HIV, compared to people without HIV. These data suggest expression of HLA-DR by Mtb-specific CD4 T cells may represent an early biomarker of increased mycobacterial antigen stimulation in people with HIV prior to the development of symptomatic tuberculosis disease.

Indexed as

CD4-Positive T-LymphocytesCoinfectionHIV InfectionsHLA-DR AntigensLatent TuberculosisMycobacterium tuberculosisAdultBiomarkersCase-Control StudiesCD40 LigandFemaleFlow CytometryHost-Pathogen InteractionsHumansInterferon-gammaKenyaBiomarkersCD40 LigandHLA-DR AntigensInterferon-gammaCD4 T cellHIVHLA-DRImmune activationLTBIMycobacterium tuberculosis

Identifiers

PMID39864237
PMCPMC11871988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.